Annamaria M. Gulla
Candiolo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Rethinking Multiple Myeloma Treatment: The Biological and Clinical Insights Guiding Immune-Based Combinations.
Journal: Blood cancer discovery
Published: August 04, 2025
ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3.
Journal: Blood cancer discovery
Published: February 03, 2025
A BCMA-mRNA vaccine is a promising therapeutic for multiple myeloma.
Journal: Blood
Published: January 27, 2025
Single-Nuclei Transcriptome Profiling Reveals Intra-Tumoral Heterogeneity and Characterizes Tumor Microenvironment Architecture in a Murine Melanoma Model.
Journal: International journal of molecular sciences
Published: September 22, 2024
Targeting Acetyl-CoA Carboxylase Suppresses De Novo Lipogenesis and Tumor Cell Growth in Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 17, 2024
Correction: BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 03, 2024
Just scratching the surface: novel treatment approaches for multiple myeloma targeting cell membrane proteins.
Journal: Nature reviews. Clinical oncology
Published: June 05, 2024
Mesenchymal stem cells: paving the way for myeloma onset?
Journal: Blood advances
Published: May 28, 2024
Editor's Note: A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 15, 2024
DAMPening Tumor Immune Escape: The Role of Endoplasmic Reticulum Chaperones in Immunogenic Chemotherapy.
Journal: Antioxidants & redox signaling
Published: February 17, 2024
Last Updated: 09/26/2026